InicioCHJTF • OTCMKTS
add
CSPC Pharmaceutical Group Ltd
0,96 $
Preapertura:(16,70 %)-0,16
0,80 $
Cerrados: 18 oct, 8:05:00 GMT-4 · USD · OTCMKTS · Renuncia de responsabilidad
Cierre anterior
0,96 $
Intervalo anual
0,54 $ - 0,96 $
Cap. bursátil
76,84 mil M HKD
Volumen medio
2,34 mil
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
HKG
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (CNY) | jun 2024info | Cambio interanual |
|---|---|---|
Ingresos | 7301,55 M | -9,04 % |
Gastos operativos | 3490,59 M | -12,37 % |
Ingresos netos | 1407,52 M | -8,49 % |
Margen de beneficio neto | 19,28 | 0,63 % |
Beneficios por acción | — | — |
EBITDA | 1943,51 M | -0,82 % |
Tipo impositivo efectivo | 18,44 % | — |
Balance general
Activos totales
Responsabilidades totales
| (CNY) | jun 2024info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 10,82 mil M | -15,16 % |
Activos totales | 47,90 mil M | 9,67 % |
Responsabilidades totales | 11,42 mil M | 12,43 % |
Patrimonio total | 36,47 mil M | — |
Acciones en circulación | 11,83 mil M | — |
Precio-valor contable | 0,33 | — |
Rentabilidad económica | — | — |
Retorno sobre capital | 11,49 % | — |
Flujo de caja
Variación neta del flujo de caja
| (CNY) | jun 2024info | Cambio interanual |
|---|---|---|
Ingresos netos | 1407,52 M | -8,49 % |
Efectivo de operaciones | — | — |
Efectivo de inversión | — | — |
Efectivo de financiación | — | — |
Variación neta del flujo de caja | — | — |
Flujo de caja libre | — | — |
Información sobre la empresa
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
Director ejecutivo
Fundación
1992
Sitio web
Empleados
20.300
